SMO and cholangiocarcinoma: In CCA cells (KMCH, HuCCT-1, Mz-Cha-1), Hh signaling was constitutively active and suppressed the expression of DR4, thereby increasing cancer cell resistance to TRAIL-induced apoptosis, an effect blunted by the Smo inhibitor cyclopamine [169].